1. INTRODUCTION
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the Study
1.4. Market Segmentation
1.5. Currency
1.6. Assumptions
1.7. Base, and Forecast Years Timeline
2. RESEARCH METHODOLOGY
2.1. Research Process
2.2. Research Data
3. EXECUTIVE SUMMARY
3.1. Key Findings
4. MARKET DYNAMICS
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. SLEEP AIDS MARKET BY PRODUCT TYPE
5.1. Introduction
5.2. Mattresses and Pillows
5.3. Medication
5.4. Sleep Laboratory Services
5.5. Others
6. SLEEP AIDS MARKET BY DISORDER
6.1. Introduction
6.2. Sleep Apnea
6.3. Insomnia
6.4. Sleepwalking
6.5. Others
7. SLEEP AIDS MARKET BY GEOGRAPHY
7.1. Introduction
7.2. North America
7.2.1. United States
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. United Kingdom
7.4.2. Germany
7.4.3. France
7.4.4. Italy
7.4.5. Spain
7.4.6. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. Japan
7.6.2. China
7.6.3. India
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
9. COMPANY PROFILES
9.1. BMC
9.2. Fisher Wallace
9.3. Koninklijke Philips N.V.
9.4. Eisai Co., Ltd.
9.5. GSK group of companies.
9.6. Natus Medical
9.7. Cadwell Industries Inc.
9.8. Sanofi
9.9. Idorsia Pharmaceuticals Ltd
9.10. Löwenstein Medical Technology GmbH + Co. KG.